Festuccia, William T.
Universidade de São Paulo
4 papers on CoChatORCID 0000-0003-4769-0806
Most cited papers
- Verified
Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia by Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue
Houde, V. P., Brûlé, S., Festuccia, W. T., Blanchard, P.-G., Bellmann, K., Deshaies, Y., & Marette, A. (2010) · Diabetes
Metabolism, Diabetes, and CancerPI3K/AKT/mTOR signaling in cancer
Cited by 456
- Verified
Mechanisms of the depot specificity of peroxisome proliferator-activated receptor γ action on adipose tissue metabolism.
Laplante, M., Festuccia, W. T., Soucy, G., Gélinas, Y., Lalonde, J., Berger, J. P., & Deshaies, Y. (2006) · Diabetes
Peroxisome Proliferator-Activated ReceptorsAdipose Tissue and Metabolism
Cited by 119
- Verified
The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis
Mouchiroud, M., Camiré, É., Aldow, M., Caron, A., Jubinville, É., Turcotte, L., Kaci, I., Beaulieu, M.-J., Roy, C., Labbé, S. M., et al. (2019) · JCI Insight
Liver Disease Diagnosis and TreatmentCholesterol and Lipid Metabolism
Cited by 57
- Verified
The Hepatokine TSK does not affect brown fat thermogenic capacity, body weight gain, and glucose homeostasis
Mouchiroud, M., Camiré, É., Aldow, M., Caron, A., Jubinville, É., Turcotte, L., Kaci, I., Beaulieu, M.-J., Roy, C., Labbé, S. M., et al. (2019) · Molecular Metabolism
Adipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases
Cited by 24
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free